Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CENTAURUS: Rosuvastatin vs Atorvastatin in Acute Coronary Syndrome
NCT00296387Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of rosuvastatin in acute coronary syndrome (ACS), sponsored by AstraZeneca. Started Jan 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00296387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296387.